G15, GPER Antagonist
G-15, GPER Antagonistis a cell permeable, nonsteroidal, high-affinity, selective antagonist of GPER that binds GPER with affinity of about 20-30 nM, 1/3 that of G-1 (AZ00001-G15)
G-15 is a cell permeable, nonsteroidal, high-affinity, selective antagonist of GPER that binds GPER with affinity of about 20-30 nM, 1/3 that of G-1 (AZ00001-G15)). G15 inhibits GPER-mediated calcium mobilization in human breast carcinoma SKBr3 cells (IC50 ~190 nM against stimulation by either 100 nM G-1 or 30 nM 17β-estradiol) in vitro and blocks G-1-induced (0.5 nmol per animal via s.c.) uterine epithelial proliferation (by ≥76% with ≥7.4 nmol G15 per animal via s.c.) in ovariectomized mice in vivo.
Formal Name | (3aS*,4R*,9bR*)-4-(6-Bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta[c]quinoline |
CAS Number | 1161002-05-6 |
Molecular Formula | C19 H16 BrNO2 |
Formula Weight | 370.2 |
Formulation | A crystalline solid |
Purity | ≥97% by HPLC (Racemic mixture) |
Stability | 2 years |
Storage | -20°C |
Shipping | Room temperature |
Solubility | DMSO up to 50mM |
GPER | Antagonist |
---|